Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2003

01-09-2003 | Brief Report

Helicobacter pylori Genotypes in Russia

Authors: K. Momynaliev, O. Smirnova, L. Kudryavtseva, V. Govorun

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2003

Login to get access

Excerpt

Numerous studies have indicated that Helicobacter pylori is one of the most frequent pathogens, affecting up to 50% of the human population worldwide [1, 2, 3]. While the majority of infected people have no clinical manifestation, they nevertheless constitute a risk group for subsequent development of chronic gastritis, gastric ulcer, duodenal ulcer, extranodal B-cell MALT lymphoma or gastric adenocarcinoma. There is evidence that genetic variability of Helicobacter pylori is related to the risk of disease. Several genes of Helicobacter pylori, such as cagA, vacA, iceA and babA are considered to be associated with virulence. …
Literature
1.
Scherbakov P (1999) The epidemiology of H. pylori infection. In: Ivashkin V, Megraud F, Lapina T (eds) Helicobacter pylori: a revolution in gastroenterology (in Russian). Triada-X Publishers, Moscow, pp 14–20
2.
Poundeyr R, Ng D (1995) The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 9 (Suppl 2):33–39
3.
Pretolani S, Bonvicini R, Gasbarrini G (1997) Epidemiology. In: Malrertheiner P, Michetti P, Price A (eds) Helicobacter pylori—an atlas. Science Press, London, pp 2.1–2.6
4.
Mitchel H, Megraud F (2002) Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter 7 (Suppl 1):8–16CrossRefPubMed
5.
Van Doorn L, Figueiredo C, Sanna R, Pena S (1998) Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol 36:2597–603PubMed
6.
Van Doorn L, Figueiredo C, Sanna R, Plaisier A, Schneeberger P, deBoer W, Qoit W (1998) Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterol 115:58–66
7.
Gerhard M, Lehn N, Neumayer N, Boren T, Rad R, Schepp W, Miehlke S, Classen M, Prinz C (1999) Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci USA 96:12778–12783CrossRefPubMed
8.
Van Doorn L, Henskens Y, Nouhan N, Verschuuren A (2000) The efficacy of laboratory diagnosis of Helicobacter pylori infections in gastric biopsy specimens is related to bacterial density and vacA, cagA, and iceA genotypes. J Clin Microbiol 38:13–17PubMed
Metadata
Title
Helicobacter pylori Genotypes in Russia
Authors
K. Momynaliev
O. Smirnova
L. Kudryavtseva
V. Govorun
Publication date
01-09-2003
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2003
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-003-0987-2

Other articles of this Issue 9/2003

European Journal of Clinical Microbiology & Infectious Diseases 9/2003 Go to the issue

Article

Chronic Bronchitis in Immunocompromised Patients: Association with a Novel Mycoplasma Species

Concise Article

Cerebral Toxoplasmosis After Autologous Peripheral Blood Stem Cell Transplantation

Article

High Frequency of Antibiotic-Associated Diarrhea due to Toxin A-Negative, Toxin B-Positive Clostridium difficile in a Hospital in Japan and Risk Factors for Infection

Concise Article

Plasmodium falciparum Cerebral Malaria Complicated by Disseminated Intravascular Coagulation and Symmetrical Peripheral Gangrene: Case Report and Review

Concise Article

Rapid Detection of Pathogenic Fungi from Clinical Specimens Using LightCycler Real-Time Fluorescence PCR

Concise Article

Long-Term Predominance of a Rare Meningococcal Phenotype in a Small Geographical Area
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits